These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 6248122)
1. Degradation of the subunits of receptor-bound human choriogonadotropin by Leydig tumor cells. Ascoli M Biochim Biophys Acta; 1980 May; 629(2):409-17. PubMed ID: 6248122 [TBL] [Abstract][Full Text] [Related]
2. Degradation of receptor-bound human choriogonadotropin by murine Leydig tumor cells. Ascoli M; Puett D J Biol Chem; 1978 Jul; 253(14):4892-9. PubMed ID: 209021 [No Abstract] [Full Text] [Related]
3. Internalization and degradation of receptor-bound human choriogonadotropin in Leydig tumor cells. Fate of the hormone subunits. Ascoli M J Biol Chem; 1982 Nov; 257(22):13306-11. PubMed ID: 6292185 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of the degradation of receptor-bound human choriogonadotropin by leupeptin. Ascoli M Biochim Biophys Acta; 1979 Sep; 586(3):608-14. PubMed ID: 224947 [TBL] [Abstract][Full Text] [Related]
5. Gonadotropin binding and stimulation of steroidogenesis in Leydig tumor cells. Ascoli M; Puett D Proc Natl Acad Sci U S A; 1978 Jan; 75(1):99-102. PubMed ID: 203945 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of the degradation of receptor-bound human choriogonadotropin by lysosomotropic agents, protease inhibitors, and metabolic inhibitors. Ascoli M; Puett D J Biol Chem; 1978 Nov; 253(21):7832-8. PubMed ID: 212438 [TBL] [Abstract][Full Text] [Related]
7. Removal of the surface-bound human choriogonadotropin results in the cessation of hormonal responses in cultured Leydig tumor cells. Segaloff DL; Ascoli M J Biol Chem; 1981 Nov; 256(22):11420-3. PubMed ID: 6271747 [TBL] [Abstract][Full Text] [Related]
8. Receptor-mediated uptake and degradation of human chorionic gonadotropin: fate of the hormone subunits. Ascoli M Ann N Y Acad Sci; 1982; 383():151-73. PubMed ID: 6283988 [No Abstract] [Full Text] [Related]
9. Demonstration of a direct effect of inhibitors of the degradation of receptor-bound human choriogonadotropin on the steroidogenic pathway. Ascoli M J Biol Chem; 1978 Nov; 253(21):7839-43. PubMed ID: 212439 [TBL] [Abstract][Full Text] [Related]
10. Role of the rate of internalization of the agonist-receptor complex on the agonist-induced down-regulation of the lutropin/choriogonadotropin receptor. Nakamura K; Lazari MF; Li S; Korgaonkar C; Ascoli M Mol Endocrinol; 1999 Aug; 13(8):1295-304. PubMed ID: 10446904 [TBL] [Abstract][Full Text] [Related]
11. Contribution of subunits to the function of luteinizing hormone/human chorionic gonadotropin recombinants. Strickland TW; Puett D Endocrinology; 1981 Dec; 109(6):1933-42. PubMed ID: 6273123 [TBL] [Abstract][Full Text] [Related]
12. Effects of hypocholesterolemia and chronic hormonal stimulation on sterol and steroid metabolism in a Leydig cell tumor. Ascoli M J Lipid Res; 1981 Nov; 22(8):1247-53. PubMed ID: 7320635 [TBL] [Abstract][Full Text] [Related]
13. Complete dissociation of gonadotropin receptor binding and signal transduction in mouse Leydig tumour cells. Obligatory role of glycosylation in hormone action. Sairam MR Biochem J; 1990 Feb; 265(3):667-74. PubMed ID: 2306206 [TBL] [Abstract][Full Text] [Related]
14. Both alpha and beta subunits of human choriogonadotropin photoaffinity label the hormone receptor. Ji I; Ji TH Proc Natl Acad Sci U S A; 1981 Sep; 78(9):5465-9. PubMed ID: 6272303 [TBL] [Abstract][Full Text] [Related]
15. Differential processing of the two subunits of human choriogonadotropin by granulosa cells. II. In vivo studies. Campbell KL; Bagavandoss P; Byrne MD; Jonassen JA; Landefeld TD; Quasney MW; Sanders MM; Midgley AR Endocrinology; 1981 Dec; 109(6):1858-71. PubMed ID: 6273119 [TBL] [Abstract][Full Text] [Related]
16. The dynamics of the steroidogenic response of perifused Leydig tumor cells to human chorionic gonadotropin, ovine luteinizing hormone, cholera toxin, and adenosine 3',5'-cyclic monophosphate. Segaloff DL; Puett D; Ascoli M Endocrinology; 1981 Feb; 108(2):632-8. PubMed ID: 6256160 [TBL] [Abstract][Full Text] [Related]
17. Progesterone action in a murine Leydig tumor cell line (mLTC-1), possibly through a nonclassical receptor type. El-Hefnawy T; Manna PR; Luconi M; Baldi E; Slotte JP; Huhtaniemi I Endocrinology; 2000 Jan; 141(1):247-55. PubMed ID: 10614645 [TBL] [Abstract][Full Text] [Related]
18. Differential processing of the two subunits of human choriogonadotropin (hCG) by granulosa cells. I. Preparation and characterization of selectively labeled hCG. Landefeld TD; Byrne MD; Campbell KL; Midgley AR Endocrinology; 1981 Dec; 109(6):1851-7. PubMed ID: 6273118 [TBL] [Abstract][Full Text] [Related]
19. A transplantable rat Leydig cell tumor: binding properties, hormonal responsiveness, and tumor growth. Erichsen A; Jahnsen T; Attramadal H; Andersen D; Hansson V Ann N Y Acad Sci; 1984; 438():655-8. PubMed ID: 6100028 [No Abstract] [Full Text] [Related]
20. Mechanisms of epidermal growth factor signaling: regulation of steroid biosynthesis and the steroidogenic acute regulatory protein in mouse Leydig tumor cells. Manna PR; Huhtaniemi IT; Wang XJ; Eubank DW; Stocco DM Biol Reprod; 2002 Nov; 67(5):1393-404. PubMed ID: 12390868 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]